addition and subtraction. Medical journals have insisted since 1988 that authors should give confidence intervals for the differences between means and proportions3 4, but the same expectation does not seem to apply to correlation coefficients.
Second, the authors have drawn lines through the four arrays presented in their Figure 1 . The lines are not defined but are probably least squares axes. But since they are not regressing the y variable (ESR) on the x variable (Hb), why are lines shown? The result is an illusion of definitiveness and precision whereas the underlying relationships are weak and obscure. Indeed the correlations are so poor that it is difficult to know whether the relationships are even linear and there is evidence that they are heteroscedastic.
Third, they place mistaken reliance on significance levels for correlation coefficients: 'In both sexes a significant inverse correlation was demonstrated in all patients and notably also in non-anaemic patients'. If populations are large, say in excess of 100 or thereabouts, correlations are always significant even if very weak and of no importance. In a large population it is almost impossible for two biological variables not to have a statistically significant relationship. It is the strength or weakness of the relationship as indicated by the correlation coefficient and the confidence interval which matter and not the P value.
Examination of their Figure 1 shows that the relationship between the ESR and Hb for males with a normal range of Hb is poor (n=381, r=-0.31, 95% CI -0.22 to -0.40) whilst that for the females is negligible (n=619, r=-0.14, 95% CI -0.06 to -0.22). The results indicate that for patients of either sex with normal haemoglobins the relation between the ESR and the Hb is trivial and of no interpretive importance. Authors' reply Though grateful to Dr Porter for his comments, we feel that a debate about the statistical strength or weakness of the relationship between Hb and ESR in patients with normal Hb may obscure the thrust of the message. We are not attaching any biological importance to this relationship and indeed we agree that the association may be too weak to do so in any meaningful way. Our concern is with the utility of the ESR estimation; variability of the result with Hb is just one of the external influences to add to the others already well-recognized. Dr Porter's comments could apply equally to sex and smoking habit; these are 'trivial' in the clinical sense. The interpretation of a very high ESR should lead to an investigative process that is appropriate and worthwhile; the question raised by our paper (and, of course, we are not the first to raise it) is whether, as a haematology laboratory, we should continue to offer a test about whose validity in borderline-raised cases we have reservations. This becomes particularly pertinent when we reflect on the several millions of pounds spent on ESR tests in the UK annually. Is the NHS getting value for money? We believe that it is precisely because of these unimportant variables that influence ESR results (strongly or weakly) that tests such as plasma viscosity may be more suitable.
Alan M W Porter

E J Kanfer B A Nicol
Department of Haematology, Royal Postgraduate Medical School, London W12 ONN, England
Private psychiatry and the NHS Dr Shah's editorial (January 1997 JRSM, pp 1-2) is inaccurate. Independent sector hospitals would be quite capable of providing community care, and indeed in some areas already do so, were there funding available for this. It is important to separate out the ability of the independent sector to provide care and the funding for such care. National Health Service (NHS) units are funded by their purchasers to provide both inpatient care and community care of various sorts. As Dr Shah rightly says, most private medical insurers are only prepared to provide for inpatient care, a limited amount of day care and consultant follow-up. Very few of the NHS purchasers who purchase from the independent sector will buy the community follow-up from the independent sector only an acute bed, either for an acute psychotic episode or for secure care. My own hospital has recently sought to provide community care as part of the local psychiatric provision, recognizing that we were in a good position to provide a very high standard of care to local patients and for local general practitioners (GPs). Despite our putting in a competitive tender to both the local health authority and a local purchasing consortium, the health authority chose to purchase their care from the local NHS provider (at a greater cost) and to insist that the local purchasing consortium, which is run jointly between the health authority, who employs the manager, and local GP fundholders, also continue to buy their service from the local NHS provider.
As somebody who has spent the bulk of his career working in the NHS in a community psychiatric service, I would welcome the ability of providing a comprehensive service from my hospital, but will be unable to do so if the purchasers remain reluctant to purchase from us.
It is unfortunate that an editorial in your journal consolidates prejudices. I too have shared many of the prejudices in the past about the 'private' but really independent sector, which comprises both private and charitable agencies, but many of the provider units in the independent sector would dearly love to be involved in comprehensive psychiatric provision. The only true way of testing this out without using the 'clout' of a statutory annual registration would be to put services out to tender and then to purchase that service which can provide the best possible care within the agreed budget.
Michael J Harris
Consultant Forensic Psychiatrist, Medical Director, St. Andrew's Hospital, Northampton NN1 5DG, England Author's reply I agree with Dr Harris that independent sector hospitals are capable of providing community care. However, the odds are
